Singapore, Aug. 18 -- GC Biopharma, a South Korean biopharmaceutical company, has signed a Memorandum of Understanding (MoU) with the Thai Red Cross Society (TRCS) to cooperate on workforce training for the production of plasma-derived medicinal products.

This MoU formalises and deepens a relationship that began in 2015, when GC Biopharma supported TRCS to establish a plasma fractionation facility inThailand, and reflects the ongoing strategic collaboration between the two parties.

Under the terms of the MoU, GC Biopharma and TRCS will jointly develop and operate on-site training and exchange programmes for local production personnel. These programmes aim to transfer GC Biopharma's advanced manufacturing technologies and expertise to su...